| Primary |
| Growth Hormone Deficiency |
20.9% |
| Drug Use For Unknown Indication |
13.1% |
| Product Used For Unknown Indication |
10.8% |
| Dwarfism |
9.6% |
| Hypopituitarism |
8.4% |
| Renal Failure Chronic |
7.4% |
| Prader-willi Syndrome |
5.2% |
| Body Height Below Normal |
4.4% |
| Azotaemia |
4.0% |
| Turner's Syndrome |
2.5% |
| Hypothalamo-pituitary Disorder |
2.5% |
| Immunosuppressant Drug Therapy |
2.2% |
| Hormone Replacement Therapy |
1.9% |
| Growth Retardation |
1.6% |
| Drug Therapy |
1.5% |
| Failure To Thrive |
0.9% |
| Pituitary Infarction |
0.9% |
| Postpartum Hypopituitarism |
0.8% |
| Cystic Fibrosis |
0.6% |
| Diabetes Insipidus |
0.6% |
|
| Death |
30.3% |
| Sudden Death |
13.0% |
| Malaise |
9.2% |
| Respiratory Tract Infection |
5.9% |
| Vomiting |
5.1% |
| Convulsion |
4.3% |
| Renal Cancer |
3.2% |
| Respiratory Failure |
3.2% |
| Headache |
3.0% |
| Meningioma |
2.7% |
| Neoplasm |
2.7% |
| Weight Increased |
2.7% |
| Weight Decreased |
2.4% |
| Epiphysiolysis |
2.2% |
| Colon Cancer Metastatic |
1.9% |
| Blood Glucose Increased |
1.6% |
| Brain Neoplasm |
1.6% |
| Neoplasm Recurrence |
1.6% |
| Pituitary Tumour Benign |
1.6% |
| Pyrexia |
1.6% |
|
| Secondary |
| Hypopituitarism |
16.1% |
| Growth Hormone Deficiency |
12.2% |
| Renal Failure Chronic |
10.7% |
| Azotaemia |
9.8% |
| Dwarfism |
8.5% |
| Body Height Below Normal |
6.5% |
| Pituitary Infarction |
5.5% |
| Postpartum Hypopituitarism |
5.4% |
| Product Used For Unknown Indication |
5.0% |
| Drug Use For Unknown Indication |
3.1% |
| Hypothalamo-pituitary Disorder |
2.8% |
| Enchondromatosis |
2.2% |
| Cachexia |
1.8% |
| Immunosuppressant Drug Therapy |
1.8% |
| Cystic Fibrosis |
1.7% |
| Growth Retardation |
1.7% |
| Chondrodystrophy |
1.5% |
| Failure To Thrive |
1.5% |
| Adrenal Insufficiency |
1.1% |
| Colitis Ulcerative |
1.1% |
|
| Death |
38.9% |
| Malaise |
8.3% |
| Vomiting |
6.3% |
| Headache |
4.9% |
| Neoplasm Progression |
4.2% |
| Retinopathy |
4.2% |
| Convulsion |
3.5% |
| Malnutrition |
2.8% |
| Renal Cancer |
2.8% |
| Renal Failure |
2.8% |
| Weight Increased |
2.8% |
| Cystic Fibrosis |
2.1% |
| Hepatic Infection Bacterial |
2.1% |
| Limb Asymmetry |
2.1% |
| Nasopharyngitis |
2.1% |
| Product Quality Issue |
2.1% |
| Respiratory Failure |
2.1% |
| T-cell Lymphoma |
2.1% |
| Thermal Burn |
2.1% |
| Transplant Failure |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.9% |
| Product Used For Unknown Indication |
23.2% |
| Crohn's Disease |
10.3% |
| Pain |
6.5% |
| Hypertension |
5.4% |
| Restless Legs Syndrome |
3.2% |
| Hypersensitivity |
2.7% |
| Ill-defined Disorder |
2.7% |
| Insomnia |
2.7% |
| Hypothyroidism |
2.2% |
| Anaemia |
1.6% |
| Anxiety |
1.6% |
| Blood Growth Hormone |
1.6% |
| Depression |
1.6% |
| Dialysis |
1.6% |
| Mood Disorder Due To A General Medical Condition |
1.6% |
| Multiple Allergies |
1.6% |
| Osteoporosis |
1.6% |
| Prophylaxis |
1.6% |
| Supplementation Therapy |
1.6% |
|
| Vomiting |
15.4% |
| Urinary Tract Infection |
10.3% |
| Sinus Disorder |
7.7% |
| Culture Urine Positive |
5.1% |
| Depression |
5.1% |
| Pain |
5.1% |
| Pathological Gambling |
5.1% |
| Pyrexia |
5.1% |
| T-cell Lymphoma |
5.1% |
| Therapeutic Response Decreased |
5.1% |
| Throat Tightness |
5.1% |
| Tremor |
5.1% |
| Acute Febrile Neutrophilic Dermatosis |
2.6% |
| Asthenia |
2.6% |
| Blood Bilirubin Unconjugated Increased |
2.6% |
| Cardiac Arrest |
2.6% |
| Cardiac Disorder |
2.6% |
| Death |
2.6% |
| Drug Ineffective |
2.6% |
| Headache |
2.6% |
|
